首页> 外文期刊>The Journal of Organic Chemistry >Isolation, Structure Elucidation, and Antitumor Activity of Spirohexenolides A and B
【24h】

Isolation, Structure Elucidation, and Antitumor Activity of Spirohexenolides A and B

机译:螺己内酯A和B的分离,结构鉴定和抗肿瘤活性

获取原文
获取原文并翻译 | 示例
       

摘要

In this report, we describe the discovery of a pair of bioactive spirotetronates, spirohexenolides A (1) and B (2), that arose from the application of mutagenesis, clonal selection techniques, and media optimization to strains of Streptomyces platensis. The structures of spirohexenolides A (1) and B (2) were elucidated through X-ray crystallography and confirmed by 1Dand 2DNMR studies.Under all examined culture conditions, spirohexenolide A (1) was the major metabolite with traces of spirohexenolide B (2) arising in cultures containing increased loads of adsorbent resins. Spirohexenolide A (1) inhibited tumor cell growth with GI50 values spanning from 0.1 to 17 μM across the NCI 60 cell line panel. Anincreased activitywas observed in leukemia (GI50 value of 254 nMinRPMI-8226 cells), lung cancer (GI50 value of 191nMinHOP-92 cells), and colon cancer (GI50 value of 565 nMinSW-620 cells) tumor cells.Metabolite 1 was fluorescent and could be examined on a confocal fluorescent microscope with conventional laser excitation and filter sets. Time lapse imaging studies indicated that spirohexenolide A (1) was readily taken up by tumor cells, appearing through the cell immediately after dosing and subcellularly localizing in the lysosomes. This activity, combined with a unique selectivity in NCI 60 cancer cell line screening, indicates that 1 warrants further chemotherapeutic evaluation.
机译:在本报告中,我们描述了对诱变,克隆选择技术和培养基优化对链霉菌菌株的应用引起的一对具有生物活性的螺旋体螺环螺内酯A(1)和B(2)的发现。通过X射线晶体学阐明了螺己内酯A(1)和B(2)的结构,并通过1D和2DNMR研究证实。在所有检查的培养条件下,螺己内酯A(1)是主要的代谢产物,带有螺螺内酯B(2)。在含有大量吸附树脂的培养物中产生。 Spirohexenolide A(1)抑制肿瘤细胞的生长,整个NCI 60细胞系的GI50值范围从0.1到17μM。在白血病(GI50值为254 nMinRPMI-8226细胞),肺癌(GI50值为191nMinHOP-92细胞)和结肠癌(GI50值为565 nMinSW-620细胞)的肿瘤细胞中发现活性增强。代谢物1具有荧光并且可以在具有常规激光激发和滤光片组的共聚焦荧光显微镜上进行检查。延时成像研究表明,螺乙己内酯A(1)容易被肿瘤细胞吸收,在给药后立即通过细胞出现并在溶酶体中亚细胞定位。该活性与NCI 60癌细胞系筛选中的独特选择性相结合,表明1需要进一步的化学治疗评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号